CRVO
CervoMed Inc.
2.50$
+0.8%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | -104.3% | -169.8% | -585.3% | |
| – | – | – | – | – | – | – | – | – | 5.7% | 14.4% | 36.2% | |
| – | – | – | – | – | – | – | – | – | -3.7% | -4.5% | 72.9% | |
| – | – | – | – | – | – | – | – | – | 0.0% | 0.0% | 0.0% | |
| – | – | – | – | – | – | – | – | – | – | -294.3% | 451.7% | |
| – | – | – | – | – | – | – | – | – | 156.0% | 476.5% | 114.5% | |
| – | – | – | – | – | – | – | – | – | 51.8% | 12.4% | -19.1% | |
| – | – | – | – | – | – | – | – | – | -104.3% | -169.8% | -585.3% |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.